← Back to all trials
Active Not Recruiting
NCT06887127
A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 350
Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd
Location: Peking Union Hospital, Chinese Academy of Medical Sciences Beijing Beijing Municipality
Summary
The primary objective of the study is to evaluate the long-term safety, tolerability, and efficacy of TLL-018 in patients with rheumatoid arthritis (RA) who have completed a preceding randomized controlled trial with TLL-018.
Eligibility Criteria
Inclusion Criteria:
* Subjects have completed TLL-018-301 study within 3 months;
* Age (at the time of consent):\>＝18 years of age, \
Source: ClinicalTrials.gov (NCT06887127). StuddyBuddy aggregates publicly available trial information.
